Surgical Specification and Efficacy Evaluation of Total Laparoscopic Left Liver Resection
NCT ID: NCT02131441
Last Updated: 2014-05-06
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
2 participants
INTERVENTIONAL
2013-07-31
2023-08-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Laparoscopic Versus Open Liver Resection in the Treatment of Hepatocellular Carcinoma
NCT01768741
Laparoscopic Versus Open Liver Resection for Hepatocellular Carcinoma
NCT02526043
Controlled Low Central Venous Pressure Combined With Hilar Block in Laparoscopic Hepatectomy
NCT03422913
A Study of Laparoscopic Hepatectomy Versus RFA in the Treatment of Recurrent HCC
NCT03313648
Selection Criteria for Safe Hepatectomy for Hepatocellular Carcinoma
NCT02056041
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
TRIPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
laparoscopic hepatectomy
laparoscopic hepatectomy
laparoscopic hepatectomy
open liver resection
open liver resection
open liver resection
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
laparoscopic hepatectomy
open liver resection
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Primary hepatocellular carcinoma of the left liver lobe
* Tumor size ≤5cm in diameter
* KPS≥60
Exclusion Criteria
* Significant abnormal Heart function
* Significant abnormal lung function
* Significant abnormal kidney function
18 Years
70 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Ya-jin Chen
Chief of the division of hepatobiliary surgery
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Sun Yat-sen Memorial Hospital,Sun Yat-sen University
Guangzhou, Guangdong, China
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2013005
Identifier Type: OTHER_GRANT
Identifier Source: secondary_id
TLLLR-001
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.